112 related articles for article (PubMed ID: 36240067)
1. Caspase-resistant ROCK1 expression prolongs survival of Eµ-Myc B cell lymphoma mice.
Mardilovich K; Naylor G; Julian L; Phinichkusolchit N; Keeshan K; Blyth K; Olson MF
Dis Model Mech; 2024 May; 17(5):. PubMed ID: 38616733
[TBL] [Abstract][Full Text] [Related]
2. B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma.
Ruddell A; Harrell MI; Furuya M; Kirschbaum SB; Iritani BM
Neoplasia; 2011 Aug; 13(8):748-57. PubMed ID: 21847366
[TBL] [Abstract][Full Text] [Related]
3. The c-Rel-c-Myc axis controls metabolism and proliferation of human T leukemia cells.
Li X; Luo G; Li T; Sun H; Wang W; Eiler E; Goldsmith JR; Chen YH
Mol Immunol; 2020 Sep; 125():115-122. PubMed ID: 32659596
[TBL] [Abstract][Full Text] [Related]
4. A common functional consequence of tumor-derived mutations within c-MYC.
Chakraborty AA; Scuoppo C; Dey S; Thomas LR; Lorey SL; Lowe SW; Tansey WP
Oncogene; 2015 Apr; 34(18):2406-9. PubMed ID: 24998853
[TBL] [Abstract][Full Text] [Related]
5. Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis.
Högstrand K; Darmanin S; Forshell TP; Grandien A
Oncotarget; 2018 Apr; 9(30):21396-21410. PubMed ID: 29765548
[TBL] [Abstract][Full Text] [Related]
6. MYC inhibitor achieves phase I success.
Crunkhorn S
Nat Rev Drug Discov; 2024 Apr; 23(4):253. PubMed ID: 38448668
[No Abstract] [Full Text] [Related]
7. Custom Workflow for the Confident Identification of Sulfotyrosine-Containing Peptides and Their Discrimination from Phosphopeptides.
Daly LA; Byrne DP; Perkins S; Brownridge PJ; McDonnell E; Jones AR; Eyers PA; Eyers CE
J Proteome Res; 2023 Dec; 22(12):3754-3772. PubMed ID: 37939282
[TBL] [Abstract][Full Text] [Related]
8. Keeping RelApse in Chk: molecular mechanisms of Chk1 inhibitor resistance in lymphoma.
Black EM; Joo YK; Kabeche L
Biochem J; 2022 Nov; 479(22):2345-2349. PubMed ID: 36416754
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the RelA(p65) Thr505 phosphosite disrupts the DNA replication stress response leading to CHK1 inhibitor resistance.
Hunter JE; Campbell AE; Butterworth JA; Sellier H; Hannaway NL; Luli S; Floudas A; Kenneth NS; Moore AJ; Brownridge PJ; Thomas HD; Coxhead J; Taylor L; Leary P; Hasoon MSR; Knight AM; Garrett MD; Collins I; Eyers CE; Perkins ND
Biochem J; 2022 Oct; 479(19):2087-2113. PubMed ID: 36240065
[No Abstract] [Full Text] [Related]
10. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.
Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N
Oncogene; 2006 Jan; 25(2):288-97. PubMed ID: 16247482
[TBL] [Abstract][Full Text] [Related]
11. The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies.
Malaney P; Velasco-Estevez M; Aguilar-Garrido P; Aitken MJL; Chan LE; Zhang X; Post SM; Gallardo M
Front Immunol; 2021; 12():634584. PubMed ID: 33912162
[TBL] [Abstract][Full Text] [Related]
12. Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma.
Winkler R; Piskor EM; Kosan C
Cells; 2022 Dec; 12(1):. PubMed ID: 36611833
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells.
Hunter JE; Campbell AE; Kerridge S; Fraser C; Hannaway NL; Luli S; Ivanova I; Brownridge PJ; Coxhead J; Taylor L; Leary P; Hasoon MSR; Eyers CE; Perkins ND
Biochem J; 2022 Oct; 479(19):2131-2151. PubMed ID: 36240067
[TBL] [Abstract][Full Text] [Related]
14. Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway.
Hunter JE; Campbell AE; Hannaway NL; Kerridge S; Luli S; Butterworth JA; Sellier H; Mukherjee R; Dhillon N; Sudhindar PD; Shukla R; Brownridge PJ; Bell HL; Coxhead J; Taylor L; Leary P; Hasoon MSR; Collins I; Garrett MD; Eyers CE; Perkins ND
Biochem J; 2022 Oct; 479(19):2063-2086. PubMed ID: 36240066
[TBL] [Abstract][Full Text] [Related]
15. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
